ECSP034692A - HISTAMINE RECEIVER ANTAGONISTS - Google Patents
HISTAMINE RECEIVER ANTAGONISTSInfo
- Publication number
- ECSP034692A ECSP034692A EC2003004692A ECSP034692A ECSP034692A EC SP034692 A ECSP034692 A EC SP034692A EC 2003004692 A EC2003004692 A EC 2003004692A EC SP034692 A ECSP034692 A EC SP034692A EC SP034692 A ECSP034692 A EC SP034692A
- Authority
- EC
- Ecuador
- Prior art keywords
- histamine
- receptor
- receiver antagonists
- histamine receiver
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona una combinación de (a) un antagonista de receptor H1 de histamina y (b) un antagonista que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor H3 de histamina que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor 3 de histamina; y sus composiciones y usos.The present invention provides a combination of (a) a histamine H1 receptor antagonist and (b) an antagonist that is at least 10 times more selective for the histamine H4 receptor compared to the histamine H3 receptor that is at least 10 times more selective for the histamine H4 receptor compared to the histamine receptor 3; and its compositions and uses.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0101223.6A GB0101223D0 (en) | 2001-01-17 | 2001-01-17 | Histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034692A true ECSP034692A (en) | 2003-08-29 |
Family
ID=9906993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004692A ECSP034692A (en) | 2001-01-17 | 2003-07-17 | HISTAMINE RECEIVER ANTAGONISTS |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP1353657A1 (en) |
| JP (1) | JP2004517883A (en) |
| KR (1) | KR20030069216A (en) |
| CN (1) | CN1486178A (en) |
| AP (1) | AP2002002401A0 (en) |
| AR (1) | AR032101A1 (en) |
| BG (1) | BG107834A (en) |
| BR (1) | BR0206502A (en) |
| CA (1) | CA2435121A1 (en) |
| CR (1) | CR6983A (en) |
| CZ (1) | CZ20031853A3 (en) |
| DO (1) | DOP2002000325A (en) |
| EA (1) | EA200300537A1 (en) |
| EC (1) | ECSP034692A (en) |
| EE (1) | EE200300335A (en) |
| GB (1) | GB0101223D0 (en) |
| GT (1) | GT200200003A (en) |
| HU (1) | HUP0302767A2 (en) |
| IL (1) | IL156087A0 (en) |
| IS (1) | IS6818A (en) |
| MA (1) | MA26980A1 (en) |
| MX (1) | MXPA03006408A (en) |
| NO (1) | NO20033223L (en) |
| OA (1) | OA12440A (en) |
| PA (1) | PA8537101A1 (en) |
| PL (1) | PL362793A1 (en) |
| PY (1) | PY0200477A (en) |
| SK (1) | SK8572003A3 (en) |
| SV (1) | SV2003000849A (en) |
| TN (1) | TNSN02003A1 (en) |
| WO (1) | WO2002056871A2 (en) |
| ZA (1) | ZA200304180B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133931A1 (en) * | 2001-12-21 | 2003-07-17 | Robin Thurmond | Use of histamine H4 receptor antagonist for the treatment of inflammatory responses |
| CA2497788A1 (en) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| US20050090527A1 (en) * | 2003-01-28 | 2005-04-28 | Schering Corporation | Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| US8236786B2 (en) * | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| PL2858647T3 (en) | 2012-06-08 | 2018-10-31 | Sensorion | H4 receptor inhibitors for treating tinnitus |
| CN119823227B (en) * | 2025-01-14 | 2025-07-04 | 广州迪卡德营养科技有限公司 | A preparation method of probiotics and use thereof in treating allergic rhinitis |
-
2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
-
2002
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/en unknown
- 2002-01-10 PL PL02362793A patent/PL362793A1/en not_active Application Discontinuation
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/en not_active Withdrawn
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/en not_active Ceased
- 2002-01-10 IL IL15608702A patent/IL156087A0/en unknown
- 2002-01-10 EP EP02732099A patent/EP1353657A1/en not_active Withdrawn
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/en unknown
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/en unknown
- 2002-01-10 CA CA002435121A patent/CA2435121A1/en not_active Abandoned
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/en unknown
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/en not_active Ceased
- 2002-01-10 CN CNA028036840A patent/CN1486178A/en active Pending
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/en not_active IP Right Cessation
- 2002-01-10 EE EEP200300335A patent/EE200300335A/en unknown
- 2002-01-10 EA EA200300537A patent/EA200300537A1/en unknown
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/en unknown
- 2002-01-14 PY PY200200200477A patent/PY0200477A/en unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/en unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/en not_active Application Discontinuation
- 2002-01-16 AR ARP020100145A patent/AR032101A1/en not_active Application Discontinuation
- 2002-01-16 GT GT200200003A patent/GT200200003A/en unknown
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/en unknown
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
-
2003
- 2003-05-15 IS IS6818A patent/IS6818A/en unknown
- 2003-05-21 BG BG107834A patent/BG107834A/en unknown
- 2003-05-22 CR CR6983A patent/CR6983A/en not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/en unknown
- 2003-07-16 NO NO20033223A patent/NO20033223L/en not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0302767A2 (en) | 2003-11-28 |
| DOP2002000325A (en) | 2003-01-31 |
| IS6818A (en) | 2003-05-15 |
| EE200300335A (en) | 2003-12-15 |
| CA2435121A1 (en) | 2002-07-25 |
| PL362793A1 (en) | 2004-11-02 |
| IL156087A0 (en) | 2003-12-23 |
| BG107834A (en) | 2004-01-30 |
| TNSN02003A1 (en) | 2005-12-23 |
| WO2002056871A2 (en) | 2002-07-25 |
| NO20033223D0 (en) | 2003-07-16 |
| JP2004517883A (en) | 2004-06-17 |
| GB0101223D0 (en) | 2001-02-28 |
| PY0200477A (en) | 2004-06-01 |
| PA8537101A1 (en) | 2002-08-29 |
| SK8572003A3 (en) | 2004-07-07 |
| BR0206502A (en) | 2003-10-21 |
| AP2002002401A0 (en) | 2002-03-31 |
| CN1486178A (en) | 2004-03-31 |
| MXPA03006408A (en) | 2003-10-15 |
| EA200300537A1 (en) | 2004-02-26 |
| OA12440A (en) | 2006-05-22 |
| NO20033223L (en) | 2003-07-16 |
| SV2003000849A (en) | 2003-01-13 |
| AR032101A1 (en) | 2003-10-22 |
| ZA200304180B (en) | 2004-06-15 |
| EP1353657A1 (en) | 2003-10-22 |
| KR20030069216A (en) | 2003-08-25 |
| CZ20031853A3 (en) | 2004-07-14 |
| CR6983A (en) | 2003-11-25 |
| GT200200003A (en) | 2002-08-19 |
| MA26980A1 (en) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3652102A (en) | Compounds and their uses | |
| PA8567001A1 (en) | ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS | |
| PA8527201A1 (en) | CYCLED PEPTIDES WITH AGONIST ACTIVITY FOR THE RECEIVER OF MELANOCORTIN-4 (MC4-R) | |
| DE60222396D1 (en) | N- (2-ARYLETHYL) BENZYLAMINE AS 5-HT6 RECEPTOR ANTAGONIST | |
| BR0015963A (en) | Muscarinic receptor antagonist urea compounds, pharmaceutical compositions comprising such compounds and method of preparing these compounds | |
| NO993350L (en) | Vitronectin receptor antagonists | |
| MX9302618A (en) | PHENYL SULFONAMIDES ENDOTHELINE ANTAGONISTS. | |
| PT1305286E (en) | CYCLOPENTANOINDOLES COMPOSITIONS CONTAINING THE REFERRED COMPOUNDS AND METHODS OF TREATMENT | |
| MXPA03002845A (en) | Association of the cb1 receptor antagonist and sibutramin, for treating obesity. | |
| HN2002000299A (en) | DERIVATIVES OF 3- AZABICICLO [3.1.0] HEXANO | |
| UY27800A1 (en) | USE OF SENAL TRANSDUCTION INHIBITORS INDIRECTED BY EGFR FOR THE TREATMENT OF HYPERPLASIA OF THE BENIGNA PROSTATE (HPS) / PROSTATE HYPERTROPHY. | |
| DOP2002000325A (en) | HISTAMINE RECEIVER ANTAGONISTS | |
| DE60132798D1 (en) | COMPOSITION OF A SODIUM CHANNEL BLOCKING COMPOUND | |
| DK1313485T3 (en) | Use of an aldosterone receptor antagonist to improve cognitive function | |
| ECSP034558A (en) | STROGEN RECEIVER MODULATORS | |
| DK0978284T3 (en) | Use of 15-keto-prostaglandin-E compounds as endothelin antagonists | |
| UY26627A1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| UY27124A1 (en) | HISTAMINE RECEIVER ANTAGONISTS | |
| ES2155187T3 (en) | BICYCLE ANTAGONISTS OF TAQUICINAS, PREPARATION OF THESE ANTAGONISTS AND ITS USE IN PHARMACEUTICAL COMPOUNDS. | |
| DK1420789T3 (en) | Use of active substances with myopioid receptor agonist and opioid receptor antagonist effect as combination drugs for cancer treatment | |
| ATE387201T1 (en) | PHARMACEUTICAL COMBINATION OF TENATOPRAZOLE AND A HISTAMINE H2 RECEPTOR ANTAGONIST | |
| MXPA04001878A (en) | Medicinal compositions containing angiotensin ii receptor antagonist. | |
| UY26893A1 (en) | PHARMACEUTICAL COMBINATION OF ANTAGONISTS OF ANGIOTENSIN II AND INHIBITORS OF THE CONVERSION ENZYME OF ANGIOTENSIN I | |
| DE60220699D1 (en) | TIBOLONFORMULIERUNGEN | |
| EP1117681A4 (en) | Novel peptides |